Ping Chen
Impact in
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 8
- Cancer, Hypoxia, and Metabolism 8
-
- Ubiquitin and proteasome pathways 17
- RNA modifications and cancer 10
- Co-authors
- Simon Bergqvist (4 shared papers)Tao Hu (13 shared papers)James Register (4 shared papers)Patrick M. O’Connor (2 shared papers)Stephen A. Margosiak (2 shared papers)Chen‐Chen Kan (2 shared papers)Kangtao Ma (3 shared papers)Chunyan Zhou (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (4 papers)Oncotarget (4 papers)Cell Death and Disease (4 papers)APOPTOSIS (3 papers)Physical review. D (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ping Chen
121 papers receiving 4.6k citations
Ping Chen's Hit Papers
Peers
Comparison fields: 5 of 124
- Hematology 614
- Genetics 469
- Cancer Research 584
- Oncology 1.1k
- Molecular Biology 2.3k
Countries citing papers authored by Ping Chen
This map shows the geographic impact of Ping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Chen more than expected).
Fields of papers citing papers by Ping Chen
This network shows the impact of papers produced by Ping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Chen. The network helps show where Ping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Discovery of N -(2-Chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical Assays Hit paper breakdown → | 2004 | 1143 |
| 2 | 2016 | 359 | |
| 3 | 2008 | 185 | |
| 4 | 2000 | 171 | |
| 5 | 2019 | 145 | |
| 6 | 1996 | 133 | |
| 7 | 2002 | 126 | |
| 8 | 2014 | 105 | |
| 9 | 2018 | 92 | |
| 10 | 2011 | 77 | |
| 11 | 1992 | 72 | |
| 12 | 2012 | 68 | |
| 13 | 2017 | 67 | |
| 14 | 2015 | 67 | |
| 15 | 2017 | 65 | |
| 16 | 1995 | 65 | |
| 17 | 2010 | 59 | |
| 18 | 2016 | 59 | |
| 19 | 2018 | 59 | |
| 20 | 2019 | 57 |
About Ping Chen
Ping Chen is a scholar working on Cancer Research, Molecular Biology, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 127 papers that have together received 4.7k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (17 papers), Cancer-related Molecular Pathways (12 papers), RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (10 papers), Photodynamic Therapy Research Studies (8 papers), MicroRNA in disease regulation (8 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Autophagy in Disease and Therapy (7 papers). The work is most often cited by research in Hematology (614 citations), Genetics (469 citations), Cancer Research (584 citations), Oncology (1.1k citations) and Molecular Biology (2.3k citations). Ping Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Simon Bergqvist, Tao Hu, James Register, Patrick M. O’Connor, Stephen A. Margosiak, Chen‐Chen Kan, Kangtao Ma, Chunyan Zhou, Zhuqing Jia and Rose Ann Ferre. Their work appears in journals such as Journal of Medicinal Chemistry, Oncotarget, Cell Death and Disease, APOPTOSIS and Physical review. D.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.